STAND. COM. REP. NO. 2218

 

Honolulu, Hawaii

                  

 

RE:    S.B. No. 2673

       S.D. 1

 

 

 

Honorable Colleen Hanabusa

President of the Senate

Twenty-Fourth State Legislature

Regular Session of 2008

State of Hawaii

 

Madam:

 

     Your Committees on Health and Education, to which was referred S.B. No. 2673 entitled:

 

"A BILL FOR AN ACT RELATING TO THE CANCER RESEARCH SPECIAL FUND,"

 

beg leave to report as follows:

 

     The purpose of this measure is to ensure the continuation of cancer research in Hawaii by supporting the expansion and financial viability of the Cancer Research Center of Hawaii.

 

     Specifically, this measure authorizes the use of deposits to the Hawaii Cancer Research Special Fund for operating expenses and capital expenditures of the Cancer Research Center of Hawaii.  This measure further provides the Cancer Research Center of Hawaii with the ability to develop other sources of revenue to finance its program requirements.

 

     Your Committees received testimony in support of this measure from the University of Hawaii System.

 

     Your Committees find that the increasing number of cancer patients has amplified the need for expanded cancer research in Hawaii.  Your Committees further find that the additional sources of revenue authorized by this measure are needed to ensure that the Cancer Research Center of Hawaii will be adequately funded.

 

     Your Committees amended this measure by making technical, nonsubstantive changes for the purposes of clarity, consistency, and style.

 

     As affirmed by the records of votes of the members of your Committees on Health and Education that are attached to this report, your Committees are in accord with the intent and purpose of S.B. No. 2673, as amended herein, and recommend that it pass Second Reading in the form attached hereto as S.B. No. 2673, S.D. 1, and be referred to the Committee on Ways and Means.

 

Respectfully submitted on behalf of the members of the Committees on Health and Education,

 

____________________________

NORMAN SAKAMOTO, Chair

 

____________________________

DAVID Y. IGE, Chair